These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. Miller N; Feng Z; Edens BM; Yang B; Shi H; Sze CC; Hong BT; Su SC; Cantu JA; Topczewski J; Crawford TO; Ko CP; Sumner CJ; Ma L; Ma YC J Neurosci; 2015 Apr; 35(15):6038-50. PubMed ID: 25878277 [TBL] [Abstract][Full Text] [Related]
6. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression. Goulet BB; Kothary R; Parks RJ Curr Mol Med; 2013 Aug; 13(7):1160-74. PubMed ID: 23514457 [TBL] [Abstract][Full Text] [Related]
7. Rescue of ATXN3 neuronal toxicity in Fardghassemi Y; Tauffenberger A; Gosselin S; Parker JA Dis Model Mech; 2017 Dec; 10(12):1465-1480. PubMed ID: 29061563 [TBL] [Abstract][Full Text] [Related]
8. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages. Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms and animal models of spinal muscular atrophy. Edens BM; Ajroud-Driss S; Ma L; Ma YC Biochim Biophys Acta; 2015 Apr; 1852(4):685-92. PubMed ID: 25088406 [TBL] [Abstract][Full Text] [Related]
10. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333 [TBL] [Abstract][Full Text] [Related]
11. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]
12. Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis. Riessland M; Kaczmarek A; Schneider S; Swoboda KJ; Löhr H; Bradler C; Grysko V; Dimitriadi M; Hosseinibarkooie S; Torres-Benito L; Peters M; Upadhyay A; Biglari N; Kröber S; Hölker I; Garbes L; Gilissen C; Hoischen A; Nürnberg G; Nürnberg P; Walter M; Rigo F; Bennett CF; Kye MJ; Hart AC; Hammerschmidt M; Kloppenburg P; Wirth B Am J Hum Genet; 2017 Feb; 100(2):297-315. PubMed ID: 28132687 [TBL] [Abstract][Full Text] [Related]
13. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice. de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977 [TBL] [Abstract][Full Text] [Related]
15. Neuron-specific knock-down of SMN1 causes neuron degeneration and death through an apoptotic mechanism. Gallotta I; Mazzarella N; Donato A; Esposito A; Chaplin JC; Castro S; Zampi G; Battaglia GS; Hilliard MA; Bazzicalupo P; Di Schiavi E Hum Mol Genet; 2016 Jun; 25(12):2564-2577. PubMed ID: 27260405 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy. Hor JH; Soh ES; Tan LY; Lim VJW; Santosa MM; Winanto ; Ho BX; Fan Y; Soh BS; Ng SY Cell Death Dis; 2018 Oct; 9(11):1100. PubMed ID: 30368521 [TBL] [Abstract][Full Text] [Related]
18. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice. Mole AJ; Bell S; Thomson AK; Dissanayake KN; Ribchester RR; Murray LM J Anat; 2020 Aug; 237(2):263-274. PubMed ID: 32311115 [TBL] [Abstract][Full Text] [Related]
19. Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Briese M; Esmaeili B; Fraboulet S; Burt EC; Christodoulou S; Towers PR; Davies KE; Sattelle DB Hum Mol Genet; 2009 Jan; 18(1):97-104. PubMed ID: 18829666 [TBL] [Abstract][Full Text] [Related]
20. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells. Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]